Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Dr Agarwal's Eye
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 69 | 79 | 84 | 76 | 81 | 100 | 102 | 95 | 100 | 117 | 118 | 116 | 120 |
| Expenses + | 48 | 56 | 61 | 55 | 56 | 69 | 72 | 69 | 68 | 80 | 78 | 82 | 86 |
| Operating Profit | 21 | 23 | 23 | 21 | 24 | 31 | 30 | 26 | 32 | 37 | 40 | 34 | 34 |
| OPM % | 30% | 29% | 28% | 27% | 30% | 31% | 29% | 27% | 32% | 32% | 34% | 30% | 28% |
| Other Income + | 0 | 0 | 1 | 1 | 2 | 0 | 2 | 2 | 0 | 1 | 1 | 3 | 2 |
| Interest | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 4 | 3 | 4 | 4 | 2 | 2 |
| Depreciation | 2 | 6 | 6 | 7 | 8 | 10 | 9 | 10 | 10 | 11 | 11 | 12 | 12 |
| Profit before tax | 18 | 16 | 17 | 13 | 17 | 19 | 19 | 14 | 19 | 23 | 26 | 23 | 21 |
| Tax % | 25% | 26% | 24% | 26% | 26% | 25% | 26% | 26% | 14% | 26% | 25% | 26% | 24% |
| Net Profit + | 14 | 12 | 13 | 9 | 13 | 14 | 14 | 10 | 16 | 17 | 19 | 17 | 16 |
| EPS in Rs | 29.11 | 24.55 | 26.79 | 20.09 | 27.21 | 30.02 | 30.11 | 22.13 | 34.02 | 36.72 | 39.98 | 35.76 | 33.60 |
Financials of Dr Agarwal's Eye
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 118 | 137 | 149 | 153 | 170 | 176 | 140 | 201 | 268 | 319 | 397 | 471 |
| Expenses + | 103 | 119 | 126 | 129 | 140 | 129 | 109 | 143 | 192 | 227 | 277 | 326 |
| Operating Profit | 15 | 18 | 23 | 24 | 30 | 47 | 31 | 59 | 76 | 92 | 120 | 145 |
| OPM % | 13% | 13% | 15% | 16% | 18% | 27% | 22% | 29% | 28% | 29% | 30% | 31% |
| Other Income + | 0 | -5 | 1 | 2 | 2 | 3 | 1 | 1 | 2 | 5 | 5 | 6 |
| Interest | 4 | 5 | 4 | 3 | 4 | 9 | 7 | 7 | 8 | 8 | 15 | 12 |
| Depreciation | 6 | 9 | 9 | 10 | 11 | 21 | 19 | 20 | 20 | 27 | 39 | 46 |
| Profit before tax | 5 | -0 | 11 | 13 | 17 | 20 | 6 | 32 | 49 | 62 | 71 | 94 |
| Tax % | -6% | -104% | 33% | 49% | 32% | 31% | 125% | 25% | 25% | 26% | 23% | 25% |
| Net Profit + | 6 | 0 | 7 | 7 | 12 | 14 | -1 | 24 | 37 | 46 | 55 | 70 |
| EPS in Rs | 12.13 | 0.09 | 15.62 | 14.43 | 25.36 | 29.11 | -3.06 | 51.28 | 78.55 | 98.64 | 116.28 | 145.05 |
| Dividend Payout % | 10% | 940% | 10% | 8% | 6% | 0% | 0% | 6% | 4% | 3% | 5% | 0% |
Financials of Dr Agarwal's Eye
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 19 | 19 | 25 | 30 | 41 | 51 | 50 | 73 | 109 | 152 | 205 | 341 |
| Borrowings + | 27 | 31 | 23 | 18 | 24 | 60 | 68 | 193 | 232 | 268 | 333 | 326 |
| Other Liabilities + | 18 | 24 | 20 | 28 | 31 | 24 | 33 | 42 | 44 | 71 | 71 | 94 |
| Total Liabilities | 69 | 79 | 72 | 81 | 100 | 141 | 155 | 314 | 390 | 496 | 613 | 766 |
| Fixed Assets + | 26 | 34 | 33 | 36 | 55 | 94 | 96 | 214 | 260 | 316 | 393 | 403 |
| CWIP | 0 | 1 | 1 | 3 | 0 | 0 | 0 | 26 | 62 | 97 | 128 | 197 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 89 |
| Other Assets + | 43 | 44 | 38 | 42 | 45 | 47 | 60 | 73 | 67 | 83 | 80 | 78 |
| Total Assets | 69 | 79 | 72 | 81 | 100 | 141 | 155 | 314 | 390 | 496 | 613 | 766 |
Financials of Dr Agarwal's Eye
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 14 | 17 | 20 | 19 | 25 | 39 | 34 | 57 | 70 | 90 | 94 | 145 |
| Cash from Investing Activity + | -10 | -17 | -8 | -11 | -25 | -17 | -11 | -46 | -71 | -70 | -133 | -174 |
| Cash from Financing Activity + | -5 | -0 | -12 | -8 | 2 | -20 | -8 | -4 | 0 | -14 | 17 | 25 |
| Net Cash Flow | -1 | 0 | 0 | -0 | 2 | 2 | 15 | 7 | -1 | 6 | -22 | -4 |
| Free Cash Flow | 3 | 1 | 12 | 7 | 0 | 22 | 23 | 10 | -1 | 19 | -8 | 47 |
| CFO/OP | 106% | 113% | 103% | 98% | 111% | 96% | 120% | 112% | 107% | 112% | 95% | 106% |
Financials of Dr Agarwal's Eye
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 19 | 24 | 16 | 17 | 19 | 14 | 23 | 16 | 14 | 15 | 13 | 14 |
| Inventory Days | 238 | 200 | 123 | 148 | 124 | 132 | 117 | 91 | 73 | 106 | 117 | 109 |
| Days Payable | 360 | 371 | 277 | 353 | 292 | 224 | 401 | 410 | 327 | 345 | 263 | 208 |
| Cash Conversion Cycle | -103 | -146 | -138 | -189 | -149 | -78 | -260 | -303 | -240 | -224 | -133 | -84 |
| Working Capital Days | -31 | -39 | -25 | -39 | -22 | -34 | -70 | -58 | -50 | -63 | -51 | 14 |
| ROCE % | 19% | 18% | 29% | 32% | 34% | 30% | 11% | 20% | 19% | 18% | 18% | 17% |
Volume-led growth with inpatient (IP) volumes up 39% and outpatient (OP) volumes up 26% year-on-year. Key concall takeaways from Manipal Health Enterprises…
IHH plans to increase its stake in Fortis to over 50% within 3-5 years, supporting long-term strategic growth. Key concall takeaways from Fortis Healthcare…
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…